Conceptualized in the year 2009, Hetero’s vertically-integrated biologics venture began with focus on key biosimilars through its Hetero Research Foundation (HRF) for some ground breaking results. Hetero’s domain expertise combined with cutting edge R&D makes things possible. In line with Hetero’s Philosophy of, “Concept to Market”, Hetero Biopharma developed its capabilities across the development, manufacturing, quality, clinical development, regulatory domains and commercialization of biosimilars from bench-to-bedside.